Alcon Abandons Effort to Purchase LENSAR After FTC Scrutiny

Alcon abandons effort to purchase LENSAR after FTC scrutiny

The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye surgery systems.

Laser focused: The Tipline for 17 March 2026

The Federal Trade Commission’s threat to sue Alcon and Lensar has derailed their planned $356 million merger in the laser eye surgery sector. “This deal should never have left the boardroom, and thanks to FTC staff's hard work it won't move forward, preserving innovation and affordable treatment options for patients,” said Commissioner Mark Meador. Also in Tipline, Apple seeks sanctions against what it calls aggressive deposition demands from pr…

Alcon and Lensar Agree to Terminate Merger Agreement

Alcon and Lensar entered an agreement to terminate their previously announced merger agreement, citing prolonged regulatory challenges and rising costs associated with the review process. The decision comes after nearly a year of regulatory scrutiny, including opposition from the U.S. Federal Trade Commission (FTC), which ultimately led both companies to conclude that continuing the transaction was no longer viable. In March 2025, Alcon and Lens…

Lensar to terminate Alcon merger agreement

Lensar has terminated its planned acquisition by Alcon, citing unresolved regulatory concerns as the main reason for ending the deal.The post Lensar to terminate Alcon merger agreement appeared first on Medical Device Network.

LENSAR Announces Termination of Merger Agreement with Alcon Research

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) — LENSAR, Inc. (Nasdaq: LNSR), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, announced that it reached an agreement with Alcon Research, LLC to terminate the merger agreement between the parties. We understand that the Federal Trade Commission intends to seek to enjoin the acquisition contemplated by the merger agreement. The Company …

Eye-surgery laser maker LENSAR drops Alcon deal after FTC move to enjoin merger

Keeps $10M deposit, scraps Alcon merger after FTC move, and sets March 31 call to detail LENSAR’s 2025 results and new standalone strategy.